Skip to content
PoliTrackerPrototype - alpha version 0.1
← Policies

Proposed

Bill · 119th Congress · S 4066

Safeguarding Women from Chemical Abortion Act

Refreshed 3 h ago

Introduced 2026-03-11Topic: health care · public health · civil rights

Summary

AI-generated summary, report an error

This bill would treat the federal approval of the drug mifepristone for ending a pregnancy, and approvals of generic versions for the same use, as withdrawn 14 days after the bill becomes law. After that, shipping the drug across state lines for that use would violate federal drug law, and mifepristone labeled for ending a pregnancy would be considered misbranded. The bill would also make manufacturers of mifepristone liable to people who suffer physical or mental health harm linked in whole or in part to using the drug. Those people could sue in federal or state court for compensatory damages, punitive damages, and attorney's fees, starting 90 days after the bill becomes law.

Full text and official record on Congress.gov

Sponsors

Action history

DateChamberActionStatus effect
2026-03-11SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.refer
2026-03-11Introduced in Senateintroduce
Source: GovInfo Bill Status (Library of Congress), fetched 2026-09-11. Provisions and opinion polling arrive in a later release.